Deerfield International Master Fund, L.P.
10% owner at EHTH; 10% owner at VNDA; 10% owner at ANTARES PHARMA, INC.
- Sold, on record
- $43M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Apr 13, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- EHTHeHealth, Inc.10% owner
- VNDAVanda Pharmaceuticals Inc.10% owner
- ANTARES PHARMA, INC.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- VNDA1.7M shares
- EHTH1.6M shares
- ANTARES PHARMA, INC.231,793 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale EHTHUnusualMar 6, 2015 2015
Sold 1.3M shares at $9.52 ($12.8M)
Deerfield International Master Fund, L.P., 10% owner
Sold 55.8% of holdings ($22.9M position)1.1M shares leftFirst sale on recordFiling
- 2 Form 4 sale ANTARES PHARMA, INC.Plan not statedJul 20, 2015 +136 days
Sold 231,793 shares at $2.17 ($503k)
Deerfield International Master Fund, L.P., 10% owner
Sold 3.7% of holdings ($13.8M position)6.1M shares leftFirst sale on recordFiling
- 3 Form 4 sale EHTHPlan not statedJun 8, 2016 +324 days
Sold 63,736 shares at $13.92 ($887k)
Deerfield International Master Fund, L.P., 10% owner
Sold 6.2% of holdings ($14.3M position)966,748 shares leftFiling
- 4 Form 4 sale VNDAUnusualSep 19, 2016 +103 days
Sold 547,886 shares at $15.67 ($8.6M)
Deerfield International Master Fund, L.P., 10% owner
Sold 37.3% of holdings ($23M position)919,718 shares leftFirst sale on recordFiling
- 5 Form 4 sale VNDAUnusualSep 23, 2016 +4 days
Sold 1.1M shares at $16.57 ($18.6M)
Deerfield International Master Fund, L.P., 10% owner
Sold 61.8% of holdings ($30M position)693,171 shares leftFiling
- 6 Form 4 sale EHTHPlan not statedApr 13, 2017 +202 days
Sold 150,000 shares at $11.00 ($1.6M)
Deerfield International Master Fund, L.P., 10% owner
Sold 13.3% of holdings ($12.4M position)975,375 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2017 | Apr 17, 2017 | EHTH | 10% owner | Form 4 sale | 150,000 | $1.6M | 13.3% | Plan not stated | SEC |
| Sep 23, 2016 | Sep 26, 2016 | VNDA | 10% owner | Form 4 sale | 1.1M | $18.6M | 61.8% | Unusual | SEC |
| Sep 19, 2016 | Sep 19, 2016 | VNDA | 10% owner | Form 4 sale | 547,886 | $8.6M | 37.3% | Unusual | SEC |
| Jun 8, 2016 | Jun 8, 2016 | EHTH | 10% owner | Form 4 sale | 63,736 | $887k | 6.2% | Plan not stated | SEC |
| Jul 20, 2015 | Jul 21, 2015 | ANTARES PHARMA, INC. | 10% owner | Form 4 sale | 231,793 | $503k | 3.7% | Plan not stated | SEC |
| Mar 6, 2015 | Mar 9, 2015 | EHTH | 10% owner | Form 4 sale | 1.3M | $12.8M | 55.8% | Unusual | SEC |